Where Will NuScale Power Stock Be in 5 Years?

NuScale posted a record net loss of $664 million in 2025 and has increased its share count by roughly 1,500% since going public, highlighting heavy dilution and ongoing funding pressure. The company still has no operating plant, with its first project now seen as unlikely before 2030 and potentially 2032 or later, despite prior expectations of 2027. Its 6-gigawatt TVA project remains a key catalyst, but delays and cancellation risk keep the outlook highly uncertain.

Analysis

The setup is less about near-term operating momentum and more about who finances the bridge to commercialization. In SMR, the market is effectively underwriting a long-dated option on regulatory scarcity, but the second-order effect is dilution: every incremental delay increases the probability that equity becomes the cheapest capital source, which compresses per-share upside even if project value improves. That makes the stock structurally vulnerable to a “good-news, bad-stock” pattern where contract milestones lift the narrative but also widen the capital burden needed to reach them.

The broader winner set is likely the nuclear supply chain, not the developer itself. If large-scale SMR deployment remains credible, engineering, modular fabrication, heavy electrical, and fuel-cycle names can benefit earlier and with lower execution risk than SMR; the real bottleneck is no longer technology approval but project finance and construction certainty. That means the market may be underpricing the duration mismatch: the industrial ecosystem can re-rate on even modest proof points, while SMR itself may need years of execution to justify a sustained multiple.

Catalyst timing is important. Over the next 6-18 months, the shares will likely trade more on financing optics and project headlines than on intrinsic operating progress, because no cash-flow inflection is in sight. A reversal would require either credible non-dilutive funding or a materially de-risked build schedule; absent that, every delay pushes the equity closer to being valued as an out-of-the-money call on the 2030s rather than a growth stock.

Consensus may be overestimating the value of first-mover advantage and underestimating the cost of being first. In regulated infrastructure, being early often means being the first to absorb cost overruns, permitting friction, and supply-chain learning curves. The contrarian takeaway is that SMR’s best risk/reward may not be outright long exposure here; it may be in owning the picks-and-shovels beneficiaries or fading enthusiasm into spikes driven by headline catalysts.

Key Decisions for Investors

• Maintain a tactical short bias in SMR on strength over the next 1-3 months; use rallies tied to project headlines as entry points, with the thesis that execution delays and financing risk will keep dilution overhang elevated.
• Pair trade: long a diversified nuclear supply-chain basket vs. short SMR for a 6-12 month horizon; this captures sector upside from SMR adoption while avoiding single-name dilution and build-risk.
• If trading options, consider buying long-dated downside protection in SMR rather than outright shares; the risk/reward improves if project timelines slip again and equity issuance resumes.
• Watch for any announced non-dilutive project financing or strategic partner capital as the key reversal trigger; if that appears, cover shorts quickly because the stock could gap higher on improved runway visibility.
• Selective long only on a confirmed de-risking event: first concrete construction milestone or final investment decision on a major project; until then, treat SMR as a financing story, not an operating one.